Pessary Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

The global pessary market is experiencing a significant upswing, with a valuation of US$ 350 million in 2024 and a promising forecast to reach US$ 700 million by the end of 2031. This remarkable growth trajectory reflects the increasing demand for pessaries as a vital alternative to surgical interventions for pelvic organ prolapse (POP) and urinary incontinence.

Key Market Drivers

The escalating prevalence of pelvic organ prolapse and urinary incontinence is a primary catalyst for the surge in demand for pessaries. These medical conditions often result in the displacement of vaginal tissues, requiring non-invasive support. Pessaries play a pivotal role in aiding women who may not be suitable candidates for surgery, offering a less complex and complication-prone solution.

About Pessaries

A pessary is a soft, removable vaginal implant designed to provide support to prolapsed pelvic organs, such as the uterus, bladder, or rectum. Notably, vaginal pessaries are considered a first-line treatment for primary stress urinary incontinence due to their high success rates and low complication rates, especially among elderly women who are more susceptible to pelvic organ prolapse.

Key Opportunities for Pessary Manufacturers

The increasing prevalence of pelvic organ prolapse presents lucrative opportunities for pessary manufacturers.
Concerns surrounding complex surgical procedures and post-operative complications bolster the appeal of pessaries as a preferred treatment option.
Growing geriatric populations, lifestyle-associated diseases, and the proven effectiveness of pessaries contribute to rapid market expansion.
The global elderly population is expected to more than double by 2050, further fueling demand for pessaries.
Pregnancy-related pressure on pelvic floor muscles enhances the prospects for pessary usage in pregnant women.

Factors Limiting Demand Growth to Some Extent

While pessaries offer significant benefits, they are not without limitations:

Prolonged use of pessaries can lead to urinary tract infections and other complications.
Discomfort, side effects, and complications, including fistulas and erosion, can deter adoption.
Finding the right pessary size and type for individual patients can be challenging.
Insertion, removal, and associated discomfort may necessitate frequent doctor visits.
Certain pessary types can cause difficulties during sexual intercourse.

Country-wise Insights

United States: With its increasing aging population, the United States continues to lead the North American pessary market. Pessaries are a preferred choice for patients unwilling or unsuitable for surgery, making them a crucial alternative treatment option.

Germany: Germany's emphasis on high-quality healthcare, government initiatives supporting women's health, and rising health issues due to sedentary lifestyles drive pessary demand.

China: China's high market share in East Asia is propelled by its growing elderly population, a surge in female urinary incontinence cases, increased disposable income, and untapped growth opportunities in diagnostics.

Competitive Landscape

The pessary market boasts a highly fragmented landscape with numerous competitors. Companies are pursuing growth strategies such as mergers, acquisitions, partnerships, collaborations, and new product launches to meet demand and expand their customer base.

Key Companies Profiled

CooperSurgical Inc.
Bliss GVS Pharma
MedGyn
Panpac Medical Corporation
Bioteque America
Personal Medical Corporation
Dr. Arabin GmbH & Co.
Kangge Medical
Integra Lifesciences
Wallach Surgical Devices
Medesign

Pessary Industry Research Segmentation

By Product:

Ring Pessaries
Lever Pessaries
Incontinence Rings
Marland
Gellhorn
Gehrung
Donuts
Cubes

By Indication:

Pelvic Organ Prolapse
Urinary Incontinences

By End User:

Hospitals
Ambulatory Surgical Centres
Speciality Clinics

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)

1. Executive Summary

1.1. Global Pessary Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Pessary Market Outlook, 2018 - 2031

3.1. Global Pessary Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Ring Pessaries
  - 3.1.1.2. Lever Pessaries
  - 3.1.1.3. Incontinence Rings
  - 3.1.1.4. Marland
  - 3.1.1.5. Gellhorn
  - 3.1.1.6. Gehrung
  - 3.1.1.7. Donuts
  - 3.1.1.8. Cubes
3.2. Global Pessary Market Outlook, by Indication, Value (US$ Mn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Pelvic Organ Prolapse
  - 3.2.1.2. Urinary Incontinences
3.3. Global Pessary Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Hospitals
  - 3.3.1.2. Ambulatory Surgical Centres
  - 3.3.1.3. Speciality Clinics
3.4. Global Pessary Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
- 3.4.1. Key Highlights
  - 3.4.1.1. North America
  - 3.4.1.2. Europe
  - 3.4.1.3. Asia Pacific
  - 3.4.1.4. Latin America
  - 3.4.1.5. Middle East & Africa

4. North America Pessary Market Outlook, 2018 - 2031

4.1. North America Pessary Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Ring Pessaries
  - 4.1.1.2. Lever Pessaries
  - 4.1.1.3. Incontinence Rings
  - 4.1.1.4. Marland
  - 4.1.1.5. Gellhorn
  - 4.1.1.6. Gehrung
  - 4.1.1.7. Donuts
  - 4.1.1.8. Cubes
4.2. North America Pessary Market Outlook, by Indication, Value (US$ Mn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Pelvic Organ Prolapse
  - 4.2.1.2. Urinary Incontinences
4.3. North America Pessary Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Hospitals
  - 4.3.1.2. Ambulatory Surgical Centres
  - 4.3.1.3. Speciality Clinics
- 4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Pessary Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. U.S. Pessary Market by Product, Value (US$ Mn), 2018 - 2031
  - 4.4.1.2. U.S. Pessary Market by Indication, Value (US$ Mn), 2018 - 2031
  - 4.4.1.3. U.S. Pessary Market by End User, Value (US$ Mn), 2018 - 2031
  - 4.4.1.4. Canada Pessary Market by Product, Value (US$ Mn), 2018 - 2031
  - 4.4.1.5. Canada Pessary Market by Indication, Value (US$ Mn), 2018 - 2031
  - 4.4.1.6. Canada Pessary Market by End User, Value (US$ Mn), 2018 - 2031
- 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Pessary Market Outlook, 2018 - 2031

5.1. Europe Pessary Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Ring Pessaries
  - 5.1.1.2. Lever Pessaries
  - 5.1.1.3. Incontinence Rings
  - 5.1.1.4. Marland
  - 5.1.1.5. Gellhorn
  - 5.1.1.6. Gehrung
  - 5.1.1.7. Donuts
  - 5.1.1.8. Cubes
5.2. Europe Pessary Market Outlook, by Indication, Value (US$ Mn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Pelvic Organ Prolapse
  - 5.2.1.2. Urinary Incontinences
5.3. Europe Pessary Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Hospitals
  - 5.3.1.2. Ambulatory Surgical Centres
  - 5.3.1.3. Speciality Clinics
- 5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Pessary Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Germany Pessary Market by Product, Value (US$ Mn), 2018 - 2031
  - 5.4.1.2. Germany Pessary Market by Indication, Value (US$ Mn), 2018 - 2031
  - 5.4.1.3. Germany Pessary Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.4.1.4. U.K. Pessary Market by Product, Value (US$ Mn), 2018 - 2031
  - 5.4.1.5. U.K. Pessary Market by Indication, Value (US$ Mn), 2018 - 2031
  - 5.4.1.6. U.K. Pessary Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.4.1.7. France Pessary Market by Product, Value (US$ Mn), 2018 - 2031
  - 5.4.1.8. France Pessary Market by Indication, Value (US$ Mn), 2018 - 2031
  - 5.4.1.9. France Pessary Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.4.1.10. Italy Pessary Market by Product, Value (US$ Mn), 2018 - 2031
  - 5.4.1.11. Italy Pessary Market by Indication, Value (US$ Mn), 2018 - 2031
  - 5.4.1.12. Italy Pessary Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.4.1.13. Turkey Pessary Market by Product, Value (US$ Mn), 2018 - 2031
  - 5.4.1.14. Turkey Pessary Market by Indication, Value (US$ Mn), 2018 - 2031
  - 5.4.1.15. Turkey Pessary Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.4.1.16. Russia Pessary Market by Product, Value (US$ Mn), 2018 - 2031
  - 5.4.1.17. Russia Pessary Market by Indication, Value (US$ Mn), 2018 - 2031
  - 5.4.1.18. Russia Pessary Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.4.1.19. Rest of Europe Pessary Market by Product, Value (US$ Mn), 2018 - 2031
  - 5.4.1.20. Rest of Europe Pessary Market by Indication, Value (US$ Mn), 2018 - 2031
  - 5.4.1.21. Rest of Europe Pessary Market by End User, Value (US$ Mn), 2018 - 2031
- 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Pessary Market Outlook, 2018 - 2031

6.1. Asia Pacific Pessary Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Ring Pessaries
  - 6.1.1.2. Lever Pessaries
  - 6.1.1.3. Incontinence Rings
  - 6.1.1.4. Marland
  - 6.1.1.5. Gellhorn
  - 6.1.1.6. Gehrung
  - 6.1.1.7. Donuts
  - 6.1.1.8. Cubes
6.2. Asia Pacific Pessary Market Outlook, by Indication, Value (US$ Mn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Pelvic Organ Prolapse
  - 6.2.1.2. Urinary Incontinences
6.3. Asia Pacific Pessary Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Hospitals
  - 6.3.1.2. Ambulatory Surgical Centres
  - 6.3.1.3. Speciality Clinics
- 6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Pessary Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. China Pessary Market by Product, Value (US$ Mn), 2018 - 2031
  - 6.4.1.2. China Pessary Market by Indication, Value (US$ Mn), 2018 - 2031
  - 6.4.1.3. China Pessary Market by End User, Value (US$ Mn), 2018 - 2031
  - 6.4.1.4. Japan Pessary Market by Product, Value (US$ Mn), 2018 - 2031
  - 6.4.1.5. Japan Pessary Market by Indication, Value (US$ Mn), 2018 - 2031
  - 6.4.1.6. Japan Pessary Market by End User, Value (US$ Mn), 2018 - 2031
  - 6.4.1.7. South Korea Pessary Market by Product, Value (US$ Mn), 2018 - 2031
  - 6.4.1.8. South Korea Pessary Market by Indication, Value (US$ Mn), 2018 - 2031
  - 6.4.1.9. South Korea Pessary Market by End User, Value (US$ Mn), 2018 - 2031
  - 6.4.1.10. India Pessary Market by Product, Value (US$ Mn), 2018 - 2031
  - 6.4.1.11. India Pessary Market by Indication, Value (US$ Mn), 2018 - 2031
  - 6.4.1.12. India Pessary Market by End User, Value (US$ Mn), 2018 - 2031
  - 6.4.1.13. Southeast Asia Pessary Market by Product, Value (US$ Mn), 2018 - 2031
  - 6.4.1.14. Southeast Asia Pessary Market by Indication, Value (US$ Mn), 2018 - 2031
  - 6.4.1.15. Southeast Asia Pessary Market by End User, Value (US$ Mn), 2018 - 2031
  - 6.4.1.16. Rest of Asia Pacific Pessary Market by Product, Value (US$ Mn), 2018 - 2031
  - 6.4.1.17. Rest of Asia Pacific Pessary Market by Indication, Value (US$ Mn), 2018 - 2031
  - 6.4.1.18. Rest of Asia Pacific Pessary Market by End User, Value (US$ Mn), 2018 - 2031
- 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Pessary Market Outlook, 2018 - 2031

7.1. Latin America Pessary Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Ring Pessaries
  - 7.1.1.2. Lever Pessaries
  - 7.1.1.3. Incontinence Rings
  - 7.1.1.4. Marland
  - 7.1.1.5. Gellhorn
  - 7.1.1.6. Gehrung
  - 7.1.1.7. Donuts
  - 7.1.1.8. Cubes
7.2. Latin America Pessary Market Outlook, by Indication, Value (US$ Mn), 2018 - 2031
7.3. Latin America Pessary Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Hospitals
  - 7.3.1.2. Ambulatory Surgical Centres
  - 7.3.1.3. Speciality Clinics
- 7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Pessary Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Brazil Pessary Market by Product, Value (US$ Mn), 2018 - 2031
  - 7.4.1.2. Brazil Pessary Market by Indication, Value (US$ Mn), 2018 - 2031
  - 7.4.1.3. Brazil Pessary Market by End User, Value (US$ Mn), 2018 - 2031
  - 7.4.1.4. Mexico Pessary Market by Product, Value (US$ Mn), 2018 - 2031
  - 7.4.1.5. Mexico Pessary Market by Indication, Value (US$ Mn), 2018 - 2031
  - 7.4.1.6. Mexico Pessary Market by End User, Value (US$ Mn), 2018 - 2031
  - 7.4.1.7. Argentina Pessary Market by Product, Value (US$ Mn), 2018 - 2031
  - 7.4.1.8. Argentina Pessary Market by Indication, Value (US$ Mn), 2018 - 2031
  - 7.4.1.9. Argentina Pessary Market by End User, Value (US$ Mn), 2018 - 2031
  - 7.4.1.10. Rest of Latin America Pessary Market by Product, Value (US$ Mn), 2018 - 2031
  - 7.4.1.11. Rest of Latin America Pessary Market by Indication, Value (US$ Mn), 2018 - 2031
  - 7.4.1.12. Rest of Latin America Pessary Market by End User, Value (US$ Mn), 2018 - 2031
- 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Pessary Market Outlook, 2018 - 2031

8.1. Middle East & Africa Pessary Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Ring Pessaries
  - 8.1.1.2. Lever Pessaries
  - 8.1.1.3. Incontinence Rings
  - 8.1.1.4. Marland
  - 8.1.1.5. Gellhorn
  - 8.1.1.6. Gehrung
  - 8.1.1.7. Donuts
  - 8.1.1.8. Cubes
8.2. Middle East & Africa Pessary Market Outlook, by Indication, Value (US$ Mn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Pelvic Organ Prolapse
  - 8.2.1.2. Urinary Incontinences
8.3. Middle East & Africa Pessary Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Hospitals
  - 8.3.1.2. Ambulatory Surgical Centres
  - 8.3.1.3. Speciality Clinics
- 8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Pessary Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. GCC Pessary Market by Product, Value (US$ Mn), 2018 - 2031
  - 8.4.1.2. GCC Pessary Market by Indication, Value (US$ Mn), 2018 - 2031
  - 8.4.1.3. GCC Pessary Market by End User, Value (US$ Mn), 2018 - 2031
  - 8.4.1.4. South Africa Pessary Market by Product, Value (US$ Mn), 2018 - 2031
  - 8.4.1.5. South Africa Pessary Market by Indication, Value (US$ Mn), 2018 - 2031
  - 8.4.1.6. South Africa Pessary Market by End User, Value (US$ Mn), 2018 - 2031
  - 8.4.1.7. Egypt Pessary Market by Product, Value (US$ Mn), 2018 - 2031
  - 8.4.1.8. Egypt Pessary Market by Indication, Value (US$ Mn), 2018 - 2031
  - 8.4.1.9. Egypt Pessary Market by End User, Value (US$ Mn), 2018 - 2031
  - 8.4.1.10. Nigeria Pessary Market by Product, Value (US$ Mn), 2018 - 2031
  - 8.4.1.11. Nigeria Pessary Market by Indication, Value (US$ Mn), 2018 - 2031
  - 8.4.1.12. Nigeria Pessary Market by End User, Value (US$ Mn), 2018 - 2031
  - 8.4.1.13. Rest of Middle East & Africa Pessary Market by Product, Value (US$ Mn), 2018 - 2031
  - 8.4.1.14. Rest of Middle East & Africa Pessary Market by Indication, Value (US$ Mn), 2018 - 2031
  - 8.4.1.15. Rest of Middle East & Africa Pessary Market by End User, Value (US$ Mn), 2018 - 2031
- 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. By Distribution Channel vs by Indication Heat map
9.2. Manufacturer vs by Indication Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
- 9.5.1. CooperSurgical Inc.
  - 9.5.1.1. Company Overview
  - 9.5.1.2. Product Portfolio
  - 9.5.1.3. Financial Overview
  - 9.5.1.4. Business Strategies and Development
- 9.5.2. Bliss GVS Pharma
  - 9.5.2.1. Company Overview
  - 9.5.2.2. Product Portfolio
  - 9.5.2.3. Financial Overview
  - 9.5.2.4. Business Strategies and Development
- 9.5.3. MedGyn
  - 9.5.3.1. Company Overview
  - 9.5.3.2. Product Portfolio
  - 9.5.3.3. Financial Overview
  - 9.5.3.4. Business Strategies and Development
- 9.5.4. Panpac Medical Corporation
  - 9.5.4.1. Company Overview
  - 9.5.4.2. Product Portfolio
  - 9.5.4.3. Financial Overview
  - 9.5.4.4. Business Strategies and Development
- 9.5.5. Personal Medical Corporation
  - 9.5.5.1. Company Overview
  - 9.5.5.2. Product Portfolio
  - 9.5.5.3. Financial Overview
  - 9.5.5.4. Business Strategies and Development
- 9.5.6. Dr. Arabin GmbH & Co.
  - 9.5.6.1. Company Overview
  - 9.5.6.2. Product Portfolio
  - 9.5.6.3. Financial Overview
  - 9.5.6.4. Business Strategies and Development
- 9.5.7. Kangge Medical
  - 9.5.7.1. Company Overview
  - 9.5.7.2. Product Portfolio
  - 9.5.7.3. Financial Overview
  - 9.5.7.4. Business Strategies and Development
- 9.5.8. Integra Lifesciences
  - 9.5.8.1. Company Overview
  - 9.5.8.2. Product Portfolio
  - 9.5.8.3. Financial Overview
  - 9.5.8.4. Business Strategies and Development
- 9.5.9. Wallach Surgical Devices
  - 9.5.9.1. Company Overview
  - 9.5.9.2. Product Portfolio
  - 9.5.9.3. Financial Overview
  - 9.5.9.4. Business Strategies and Development
- 9.5.10. Medesign
  - 9.5.10.1. Company Overview
  - 9.5.10.2. Product Portfolio
  - 9.5.10.3. Financial Overview
  - 9.5.10.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations